A Strategic and Theoretical Study of Cancer in National Hospital for Oncology and Hematology
DOI:
https://doi.org/10.64354/12awvv92Keywords:
Hematology, Oncology and Hematology, cancers, Radiation therapy.Abstract
Radiation therapy is a cornerstone and highly effective treatment for malignant tumors. It has witnessed rapid technological and methodological advancements aimed at achieving a balance between delivering the necessary dose to eradicate the tumor and minimizing damage to surrounding healthy tissues. The biological effects of radiation depend on several factors, including the dose, the type of radiation, and tissue sensitivity. This can lead to complications ranging from acute effects, such as inflammation of the mucous membranes (especially in head and neck cancers), to chronic effects such as osteoporosis and bone loss.
To ensure radiation safety, protection procedures are based on fundamental principles including justification, optimization, and dose control. The training of medical personnel and the use of modern monitoring technologies are also crucial to minimizing errors that may arise from the interaction between human factors and operational technologies and systems.
Chemotherapy is also used, either alone or in conjunction with radiation therapy, particularly in advanced cases or those inoperable. While this therapeutic integration enhances treatment efficacy, it may also increase toxicity, necessitating meticulous dose planning and continuous monitoring of side effects.
On the practical side of the study, a field review was conducted of all procedures followed at the National Oncology and Hematology Hospital, including workflow, patient management mechanisms, and treatment preparation methods and types, to compare them with approved international protocols and procedures. The results demonstrated a high degree of conformity with global standards, enhancing the reliability and efficiency of the institution's medical performance. This study is among the first to address this type of comparative evaluation.
Future directions focus on developing advanced radiotherapy techniques and targeted pharmacotherapy to improve treatment efficacy and reduce risks, while emphasizing the importance of continuous evaluation and the application of preventive measures to ensure patient safety and improve clinical outcomes.
References
1. Herskovic A, Martz K, al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326(24):1593–1598.
2. Delaney G, Jacob S, Featherstone C, Barton M. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer. 2005;104(6):1129–1137.
3. Durante M, Loeffler JS. Charged particles in radiation oncology. Nat Rev Clin Oncol. 2010;7(1):37–43.
4. Begg AC, Stewart FA, Vens C. Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer. 2011;11(4):239–253.
5. Baskar R, Lee KA, Yeo R, Yeoh KW. Cancer and radiation therapy: current advances and future directions. Int J Med Sci. 2012;9(3):193–199.
6. Cooper JS, Zhang Q, Pajak TF, et al. Long-term follow-up of the RTOG 9501/intergroup phase III trial of postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2012;84(5):1198–1205.
7. Stahl M, Walz MK, Stuschke M, et al. Phase III comparison of preoperative chemotherapy versus chemoradiotherapy in patients with locally advanced esophageal cancer. J Clin Oncol. 2013;31(23):2787–2794.
8. Baumann M, Krause M, Overgaard J, et al. Radiation oncology in the era of precision medicine. Nat Rev Cancer. 2016;16(4):234–249.
9. Hall EJ, Giaccia AJ. Radiobiology for the Radiologist. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2019.
10. Gunderson LL, Tepper JE. Clinical Radiation Oncology. 5th ed. Philadelphia: Elsevier; 2020.
11. Upadhyay RK. Radiation therapeutics and its acute effects on human body. Sci Educ Publishing; 2017.
12. World Health Organization (WHO). Radiotherapy risk profile: technical manual. Geneva: WHO; 2018.
13. International Commission on Radiological Protection (ICRP). Radiological protection in medicine. Ann ICRP. 2007;37(6):1–63.
14. National Center for Biotechnology Information (NCBI). Biological effects of ionizing radiation [Internet]. Bethesda (MD): NCBI; 2020 [cited 2026 Apr 5]. Available from: https://www.ncbi.nlm.nih.gov
15. Medscape. Radiation toxicity overview [Internet]. New York: Medscape; 2019 [cited 2026 Apr 5]. Available from: https://www.medscape.com
16. Cureus Journal. Radiation therapy and its side effects in cancer treatment. Cureus. 2020;12(5):e8310.
17. Durante M, Cucinotta FA. Heavy ion radiobiology: fundamentals and applications. Nat Rev Clin Oncol. 2011;8(1):37–48.
18. Bentzen SM. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer. 2006;6(9):702–713.
19. Hall EJ. Radiobiology for the Radiologist. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2012.
20. Bernstein MB, Krishnan S, Haffty BG. Radiotherapy and radiosensitizers in breast cancer. J Clin Oncol. 2008;26(13):2110–2116.
21. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):7–33.
22. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2020: GLOBOCAN estimates. CA Cancer J Clin. 2021;71(3):209–249.
23. DeVita VT Jr, Lawrence TS, Rosenberg SA. DeVita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology. 11th ed. Philadelphia: Lippincott Williams & Wilkins; 2019.
24. Porter AT. Evidence-based radiation oncology: systematic reviews of radiation therapy in lung cancer. Lancet Oncol. 2018;19(2):e77–e91.
25. Pignon JP, le Maître A, Maillard E, Bourhis J; MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH NC). Radiother Oncol. 2009;92(1):4–14.
26. Shilkrut M, Likhacheva A. Basic principles of chemoradiotherapy. Semin Radiat Oncol. 2018;28(4):261–274.
27. Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 2003;22(47):7265–7279.
28. Chabner BA, Longo DL. Cancer Chemotherapy and Biotherapy: Principles and Practice. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2019.
29. Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer. 2004;4(4):253–265.
30. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: Three meta analyses of updated individual data. Lancet. 2000;355(9208):949–955.
31. Tannock IF, Hill RP, Bristow RG, Harrington L. The Basic Science of Oncology. 5th ed. New York: McGraw Hill; 2018.
32. National Cancer Institute (NCI). NCI Radiation Therapy and You: Support for People With Cancer [Internet]. Bethesda (MD): NCI; 2023 [cited 2026 Apr 6]. Available from: https://www.cancer.gov
33. National Cancer Institute (NCI). NCI Chemotherapy Drugs List [Internet]. Bethesda (MD): NCI; 2024 [cited 2026 Apr 6]. Available from: https://www.cancer.gov
34. Trotti A, Garden AS, Moiseenko V, et al. Longitudinal assessment of radiation related toxicity in head and neck cancer: Radiation Therapy Oncology Group RTOG 0615. Int J Radiat Oncol Biol Phys. 2016;95(1):47–56.
35. Pápai Z, Fodor J, Szigeti GP, et al. Acute and late toxic effects of adjuvant radiochemotherapy in head and neck cancers. Orv Hetil. 2017;158(33):1305–1313.
36. Joiner MC, van der Kogel AJ. Basic Clinical Radiobiology. 5th ed. Boca Raton: CRC Press; 2021.
37. Nguyen PL, Nguyen QN, Rehman S, et al. Precision radiotherapy in the era of immunotherapy. Lancet Oncol. 2020;21(3):e162–e171.
38. Siddons H, Vermorken JB, Harrington KJ. Combining radiotherapy and systemic therapy in head and neck cancer: current evidence and future directions. Expert Rev Anticancer Ther. 2013;13(4):463–475.
39. Chuong MD, Wang X, Fraass BA, et al. Intensity modulated radiation therapy (IMRT): clinical outcomes and opportunities. Radiat Oncol. 2016;11:49.
40. Sgouros G, Hobbs R, Butler R, et al. Radionuclide therapy: principles and practices. Cancer Biother Radiopharm. 2010;25(1):1–17.
41. World Health Organization (WHO). Radiotherapy risk profile: technical manual. Geneva: WHO; 2018.
42. International Commission on Radiological Protection (ICRP). Radiological protection in medicine. Ann ICRP. 2007;37(6):1–63.
43. Upadhyay RK. Radiation therapeutics and its acute effects on human body. Sci Educ Publishing; 2017.
44. Medscape. Radiation toxicity overview [Internet]. New York: Medscape; 2019 [cited 2026 Apr 6]. Available from: https://www.medscape.com
45. Cureus Journal. Radiation therapy and its side effects in cancer treatment. Cureus. 2020;12(5):e8310.
46. DeVita VT Jr, Hellman S, Rosenberg SA. Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2015.
47. Abeloff MD, Armitage JO, Niederhuber JE, et al. Abeloff’s Clinical Oncology. 6th ed. Philadelphia: Elsevier; 2020.
48. Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ. Cancer Management: A Multidisciplinary Approach. 15th ed. Shelton: People’s Medical Publishing; 2018.
49. Seymour L, Ivy SP, Judson I. Chemotherapy: mechanisms of action and side effects. Nat Rev Drug Discov. 2019;18(4):273–292.
50. Perez EA. Principles of drug dosing, scheduling, and toxicity management in cancer therapy. J Clin Oncol. 2017;35(21):2415–2423.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 New Journal of Biology and Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
